Octavio Espinoza insider trades

Open-market stock purchases and sales by Octavio Espinoza, Chief Financial Officer at Ligand Pharmaceuticals Inc, from SEC Form 4 filings since Nov 9, 2022.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +196%.

Recent trades

DateStockTradeValue
Aug 12, 2026LGND Ligand Pharmaceuticals IncSold$9.2M
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)$855K
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)$145K
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)$160K
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)$410K
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)$230K
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Aug 12, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Jun 30, 2026LGND Ligand Pharmaceuticals IncBought (not open market)$2.7K
May 27, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
May 27, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Mar 11, 2026LGND Ligand Pharmaceuticals IncSold$688K
Mar 11, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$139K
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$10.6K
Mar 4, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$140K
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$192K
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$141K
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$136K
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$152K
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$300K

Companies traded

  • LGND Ligand Pharmaceuticals Inc: 2 buys, 25 sales, last Aug 12, 2026

Get free alerts when Octavio Espinoza files a new trade →